Top Breast Cancer Experts Highlight Key Abstracts Ahead of 2026 ESMO Congress in Berlin

Leading breast oncologists are sharing the abstracts they consider most important as the European Society for Medical Oncology (ESMO) Breast Cancer Congress approaches in Berlin from May 6 to 8, 2026.

The preview features insights from Sarah Sammons, MD, of the Dana‑Farber Cancer Institute and Harvard Medical School, clinical fellow Paolo Tarantino, MD, PhD, also at Dana‑Farber, and Sara M. Tolaney, MD, MPH, chief of the Division of Breast Oncology at Dana‑Farber and Harvard faculty.

All three emphasize that the meeting will showcase numerous sub‑analyses and updates that could influence treatment decisions or help prioritize future research directions.

Their comments suggest that attendees can expect a mix of data that may refine current practice and highlight emerging trends in breast cancer care.